Nevro Debt to Equity Ratio 2013-2019 | NVRO
Current and historical debt to equity ratio values for Nevro (NVRO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nevro debt/equity for the three months ending September 30, 2019 was 0.91.
| Nevro Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-09-30 | $0.18B | $0.20B | 0.91 |
| 2019-06-30 | $0.18B | $0.20B | 0.89 |
| 2019-03-31 | $0.18B | $0.21B | 0.83 |
| 2018-12-31 | $0.15B | $0.25B | 0.62 |
| 2018-09-30 | $0.15B | $0.24B | 0.62 |
| 2018-06-30 | $0.15B | $0.25B | 0.61 |
| 2018-03-31 | $0.15B | $0.24B | 0.61 |
| 2017-12-31 | $0.15B | $0.25B | 0.58 |
| 2017-09-30 | $0.14B | $0.24B | 0.59 |
| 2017-06-30 | $0.14B | $0.24B | 0.59 |
| 2017-03-31 | $0.14B | $0.24B | 0.58 |
| 2016-12-31 | $0.14B | $0.25B | 0.56 |
| 2016-09-30 | $0.14B | $0.25B | 0.55 |
| 2016-06-30 | $0.14B | $0.25B | 0.55 |
| 2016-03-31 | $0.02B | $0.23B | 0.09 |
| 2015-12-31 | $0.02B | $0.24B | 0.08 |
| 2015-09-30 | $0.02B | $0.24B | 0.08 |
| 2015-06-30 | $0.02B | $0.26B | 0.08 |
| 2015-03-31 | $0.02B | $0.16B | 0.12 |
| 2014-12-31 | $0.02B | $0.17B | 0.11 |
| 2014-09-30 | $0.00B | $-0.11B | 0.00 |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.00B | 0.00 | |
| 2013-09-30 | $0.00B | 0.00 | |
| 2012-12-31 | $0.00B | $-0.06B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.491B | $0.387B |
| Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and the Nevro logo are trademarks of the company. Nevro Corp. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $125.466B | 25.99 |
| Intuitive Surgical (ISRG) | United States | $66.944B | 52.61 |
| Edwards Lifesciences (EW) | United States | $51.008B | 46.32 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.998B | 14.89 |
| IDEXX Laboratories (IDXX) | United States | $21.331B | 51.59 |
| DexCom (DXCM) | United States | $20.929B | 187.43 |
| Olympus (OCPNY) | Japan | $20.322B | 152.62 |
| Teleflex (TFX) | United States | $16.317B | 33.13 |
| Sysmex ADR (SSMXY) | Japan | $14.806B | 39.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.376B | 0.00 |
| Hologic (HOLX) | United States | $13.860B | 21.18 |
| STERIS (STE) | Ireland | $12.894B | 28.48 |
| Varian Medical Systems (VAR) | United States | $12.305B | 29.17 |
| ABIOMED (ABMD) | United States | $8.631B | 46.97 |
| Masimo (MASI) | United States | $8.300B | 49.56 |
| Penumbra (PEN) | United States | $5.971B | 194.35 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Globus Medical (GMED) | United States | $5.562B | 34.33 |
| Integra LifeSciences Holdings (IART) | United States | $5.194B | 22.32 |
| Elekta AB (EKTAY) | Sweden | $4.693B | 36.13 |
| Tandem Diabetes Care (TNDM) | United States | $4.041B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.967B | 28.56 |
| Wright Medical Group (WMGI) | Netherlands | $3.760B | 227.92 |
| Cantel Medical (CMD) | United States | $3.304B | 32.75 |
| Integer Holdings (ITGR) | United States | $2.492B | 17.06 |
| Nihon Kohden (NHNKY) | Japan | $2.389B | 24.04 |
| Glaukos (GKOS) | United States | $2.224B | 0.00 |
| Inogen (INGN) | United States | $1.615B | 50.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.592B | 31.34 |
| Veracyte (VCYT) | United States | $1.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.166B | 133.26 |
| Silk Road Medical (SILK) | United States | $1.074B | 0.00 |
| Natus Medical (NTUS) | United States | $1.072B | 25.79 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.015B | 37.62 |
| CryoLife (CRY) | United States | $0.926B | 94.92 |
| Luminex (LMNX) | United States | $0.925B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.852B | 28.29 |
| Accelerate Diagnostics (AXDX) | United States | $0.799B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.783B | 0.00 |
| AxoGen (AXGN) | United States | $0.673B | 0.00 |
| Intersect ENT (XENT) | United States | $0.665B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.579B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.573B | 20.59 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ViewRay (VRAY) | United States | $0.441B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.433B | 13.10 |
| Si-Bone (SIBN) | United States | $0.433B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.422B | 0.00 |
| Sientra (SIEN) | United States | $0.406B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.317B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 39.27 |
| Stereotaxis (STXS) | United States | $0.291B | 0.00 |
| IRadimed (IRMD) | United States | $0.258B | 36.27 |
| SeaSpine Holdings (SPNE) | United States | $0.250B | 0.00 |
| Accuray (ARAY) | United States | $0.249B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.228B | 63.60 |
| Fluidigm (FLDM) | United States | $0.166B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.156B | 41.38 |
| RTI Surgical (RTIX) | United States | $0.133B | 36.00 |
| ConforMIS (CFMS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.109B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.107B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.085B | 0.00 |
| Electromed (ELMD) | United States | $0.084B | 30.00 |
| Vermillion (VRML) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.060B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.058B | 0.00 |
| TransEnterix (TRXC) | United States | $0.048B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.047B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.042B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.038B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.023B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.021B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.016B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.016B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 21.07 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Avinger (AVGR) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.011B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
